Sanjay G. Revankar

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

Posaconazole as Salvage Therapy for Zygomycosis

Richard N. Greenberg, Kathleen M. Mullane, J.-A. H. van Burik et al. · Antimicrobial Agents and Chemotherapy · 2005 · 552 citations · Full text

In Vitro Amphotericin B Resistance in Clinical Isolates of <i>Aspergillus terreus</i> , with a Head-to-Head Comparison to Voriconazole

Deanna A. Sutton, Stephen Sanche, Sanjay G. Revankar et al. · Journal of Clinical Microbiology · 1999 · 251 citations · Full text

Genetic Diversity of Human Pathogenic Members of the <i>Fusarium oxysporum</i> Complex Inferred from Multilocus DNA Sequence Data and Amplified Fragment Length Polymorphism Analyses: Evidence for the Recent Dispersion of a Geographically Widespread Clonal Lineage and Nosocomial Origin

Kerry O’Donnell, Deanna A. Sutton, Michael G. Rinaldi et al. · Journal of Clinical Microbiology · 2004 · 233 citations · Full text

Detection of <i>Candida dubliniensis</i> in Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates

William R. Kirkpatrick, Sanjay G. Revankar, Robert K. McAtee et al. · Journal of Clinical Microbiology · 1998 · 187 citations · Full text